Meningioma is a typically benign (non-cancerous) tumor that develops in the protective layers surrounding the brain and spinal cord. While most meningiomas grow slowly and cause no symptoms, some may require medical intervention.
The general risk of developing a meningioma is about 9 per 100,000 people per year. In individuals using Depo-Provera, the risk is slightly higher at 13 per 100,000 people per year.
Meningiomas are rare, and the slight increase in risk associated with Depo-Provera use remains low. However, if you have a personal or family history of meningioma, consult with your healthcare provider to discuss the best contraceptive options for you.
Routine screening for meningioma is not necessary unless you experience symptoms such as:
If you have questions about Depo-Provera, its benefits, or potential risks, our team is here to help. Schedule an appointment with your provider to discuss whether this contraceptive method is right for you.